Genzyme, a Sanofi company announced today that the European Commission has granted marketing authorization for Lemtrada(TM). This follows the August 30th approval of Aubagio(R). The company intends to begin launching both products in the EU soon.
"The approvals of Lemtrada and Aubagio in the European Union represent an important milestone for Genzyme and demonstrate our focus on scientific innovation and commitment to multiple sclerosis patients," said Genzyme CEO and President, David Meeker, M.D. "This is particularly exciting as the EU approval is the first for Lemtrada globally. We look forward to making these unique therapies available to MS patients very soon............" - Read More - http://www.ms-uk.org/lemtrada
Oral MS drug Lemtrada approved by European Commission
Oral MS drug Lemtrada approved by European Commission
MS-UK - http://www.ms-uk.org/
-
- Getting to Know You...
- Posts: 19
- Joined: Sun Mar 17, 2013 8:13 am
- Location: Southeast WI, USA
Re: Oral MS drug Lemtrada approved by European Commission
This title is misleading. Lemtrada is an IV infusion, as the stomach would destroy the drug if taken orally.
Diagnosed with RRMS March 2013.
Rebif May 2013 - September 2014.
Gilenya since November 2014.
EDSS 3.
Rebif May 2013 - September 2014.
Gilenya since November 2014.
EDSS 3.
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1070 Views
-
Last post by frodo
-
- 1 Replies
- 1144 Views
-
Last post by Petr75
-
- 0 Replies
- 156 Views
-
Last post by NHE
-
- 0 Replies
- 546 Views
-
Last post by NHE
-
- 0 Replies
- 1678 Views
-
Last post by NHE
-
- 1 Replies
- 3174 Views
-
Last post by Tif
-
- 0 Replies
- 162 Views
-
Last post by DIM
-
- 2 Replies
- 1106 Views
-
Last post by DIM
-
- 1 Replies
- 2008 Views
-
Last post by raceya